Introduction {#S0001}
============

The intervertebral discs are cartilaginous joints connecting the vertebral bodies that function by transmitting loads through the spinal column and imparting normal mobility. Each intervertebral disc is comprised of an internal gelatinous nucleus pulposus, the surrounding collagen-rich annulus fibrosus, and the cartilage endplates connecting the disc to the adjacent vertebral bodies. Increases in the internal pressure of the intervertebral disc convey stretch forces to the annulus. If these forces exceed the capacity of the annulus to withstand them, the annulus may tear, disc material may exit through the defect and enter the spinal canal, and nerve root compression with local inflammation may ensue. Herniation of a lumbar intervertebral disc is a common incidental radiographic finding in adults,[@CIT0001] with the prevalence increasing from 29% at age 20 to 43% at age 80.[@CIT0002] Imaging evidence of lumbar disc herniation requires no specific treatment unless the patient experiences associated sciatica or neurological deficits that are resistant to conservative therapy.

Approximately 1--5% of the general population experience sciatica each year, most commonly due to lumbar disc herniation.[@CIT0003] While most sciatica episodes eventually resolve with or without treatment, approximately 20% of affected individuals suffer from debilitating symptoms that are refractory to conservative management.[@CIT0004],[@CIT0005] In these patients, accumulating evidence suggests that lumbar discectomy offers faster and more durable pain relief compared to continued nonsurgical management.[@CIT0006],[@CIT0007] A meta-analysis of comparative studies with at least 1-year follow-up concluded that surgery offered greater reductions in leg pain compared to nonsurgical treatments.[@CIT0008] The most common surgical technique for treatment of symptomatic lumbar disc herniation is lumbar discectomy.[@CIT0009]

Contemporary lumbar discectomy surgery involves a limited approach in which extradiscal nuclear material is excised to decompress the adjacent nerve root with little to no removal of disc material within the intervertebral space.[@CIT0010] Compared to aggressive discectomy techniques, limited lumbar discectomy preserves disc height and lowers the risk of future lumbar degenerative changes at the expense of a higher reherniation risk.[@CIT0015] Following removal of the offending disc material, the defect in the annulus fibrosus is typically left unrepaired. Since the annulus fibrosus has limited capacity for healing,[@CIT0011] the residual annular defect serves as a constant potential pathway by which remaining disc material may reherniate, resulting in symptom recurrence. Small (\<6 mm width) annular defects do not confer an elevated risk of reherniation, but patients with large defects (≥6 mm width) comprise a high-risk subset with a 2- to 3-fold increase in reherniation risk.[@CIT0012] Thus, patients with large annular defects are appropriate candidates for additional intraoperative treatments intended to reduce the risk of reherniation.

Numerous studies have reported clinically important reductions in reherniation and reoperation rates in patients treated with lumbar discectomy and additional implantation with a bone-anchored annular closure device (ACD) compared to patients treated with lumbar discectomy alone.[@CIT0013],[@CIT0014] The ACD (Barricaid, Intrinsic Therapeutics, Woburn, MA, USA) is comprised of an occlusion component to physically block the annular defect and a titanium anchor to secure the occlusion component to an adjacent vertebral body. Based on safety and efficacy data derived from preclinical and clinical studies, the ACD received marketing approval by the US Food and Drug Administration in February 2019. Because most patients in clinical studies of the ACD were middle aged, it remains unclear whether the favorable outcomes demonstrated with the ACD are generalizable to older patients. Investigation of sciatica treatments in older adults is an important pursuit since affected individuals suffer from disability levels comparable to those with a history of chronic obstructive pulmonary disease, stroke, or myocardial infarction.[@CIT0022] Thus, the purpose of this study was to compare the efficacy of lumbar discectomy with or without a bone-anchored ACD among older (≥60 years) versus younger (\<60 years) patients with large postsurgical annular defects.

Methods {#S0002}
=======

Study design {#S0002-S2001}
------------

The primary findings of this report were derived from 3-year results of a randomized trial conducted at 21 sites involving patients with a large annular defect at completion of a lumbar discectomy procedure who received additional implantation with an ACD (276 patients) or no additional interoperative treatment (278 patients). A total of 19 patients in each group were older adults (≥60 years). Given the relatively small number of older adults treated with the ACD in this randomized trial, we supplemented this report with data from two large postmarket ACD registries.

Randomized trial {#S0002-S2002}
----------------

This multicenter randomized trial was approved by local ethics committees (listed in [Table S1](#ST0001)), and all participants provided written informed consent. The trial was prospectively registered at ClinicalTrials.gov (NCT01283438). Eligible adults aged 21--75 years presented with radicular symptoms that were refractory to at least 6 weeks of conservative management. Preoperative imaging tests included magnetic resonance imaging (MRI) of the lumbar spine, low-dose computed tomography (CT) at the level of herniation, and flexion/extension x-rays. The correlation of imaging-confirmed lumbar disc herniation with clinical symptoms was determined by a positive straight leg test or femoral stretch test. Minimum symptom severity thresholds were 40/100 for leg pain severity on a visual analogue scale (VAS) and 40/100 for back dysfunction on the Oswestry Disability Index (ODI). Patients with lumbar spine osteoporosis, significant spondylolisthesis, previous surgery at the level of herniation, active infection, or spinal tumor were not eligible for the trial. Patients who met initial eligibility criteria were scheduled for lumbar discectomy during which a final eligibility criterion was evaluated.

All patients were treated with limited lumbar discectomy in which extradiscal nuclear material was excised to relieve nerve root compression, but no attempts were made to remove significant amounts of intradiscal material.[@CIT0010] After the discectomy procedure was completed, the final eligibility assessment was performed. The size of the surgically induced defect in the annulus fibrosus was measured with a specialized tool. In patients with small annular defects, discectomy was concluded and patients were discontinued from the study owing to their low risk of future reherniation.[@CIT0012] Patients with large annular defects measuring at least 6 mm in width were intraoperatively randomized (1:1) to receive additional implantation with an ACD or to receive no additional treatment (controls).

In patients assigned to the ACD group, a bone-anchored ACD was implanted as a stand-alone procedure following the lumbar discectomy. A sizing trial was performed under fluoroscopic control to establish the correct access trajectory and placement of the device. Next, the ACD was implanted under fluoroscopic guidance by placing the occlusion component in the annular defect to prevent future expulsion of disc material into the extradiscal space. After fluoroscopic confirmation of correct device placement, the surgical site was inspected and standard wound closure was performed. Perioperative care was at the discretion of each hospital.

Patients returned for follow-up visits at 6 weeks, 3 months, 6 months, and annually for 3 years. Physical and neurological examinations, as well as lateral and anteroposterior x-rays, were performed at each visit; MRI, CT, and flexion/extension x-rays were performed annually. Patients presenting with symptoms indicative of reherniation received imaging at the time of presentation to confirm the diagnosis. Reoperations at the level of the original herniation were recorded throughout follow-up. Key patient-reported outcomes included leg pain severity, ODI, SF-36 Physical Component Summary (PCS) score, and SF-36 Mental Component Summary (MCS) score.

Preoperative patient characteristics were reported using the mean and standard deviation (SD) or the count and percentage. The minimum clinically important difference (MCID) was defined as a ≥20-point decrease from baseline for leg pain,[@CIT0016] a ≥15-point decrease from baseline for ODI,[@CIT0017] a ≥5.7-point increase from baseline for PCS,[@CIT0018] and a ≥6.3-point increase from baseline for MCS.[@CIT0018] Severe disability in follow-up was defined by an ODI score \>40/100.[@CIT0017] Cox proportional hazard models were developed to determine the association of baseline patient characteristics with the risk of symptomatic reherniation and reoperation following lumbar discectomy. Statistical analyses were performed using Stata v14.2 (StataCorp).

Postmarket ACD registries {#S0002-S2003}
-------------------------

Due to the limited number of older adults enrolled in the randomized trial, supplementary data were provided by two postmarket ACD registries, with study oversight separately provided by study authors (AA and AK). Each registry was approved by an ethics committee (Klinikum Itzehoe, Itzehoe, Germany; Donauisar Klinikum Deggendorf, Deggendorf, Germany), and all participants provided written informed consent. Complete eligibility criteria, methodology, and main study results from each of these registries were previously published,[@CIT0019]--[@CIT0021] but the influence of patient age on ACD performance was not reported. Patients in each registry were treated with limited lumbar discectomy and received additional bone-anchored ACD implantation following verification of a large annular defect. Patient eligibility requirements were generally comparable to the randomized trial, but fewer criteria were applied since these were postapproval registries of patients treated in real-world conditions. Key outcomes in the registries were symptomatic reherniation, reoperation, leg pain severity, and ODI over a minimum of 2 years follow-up.

Results {#S0003}
=======

Randomized trial {#S0003-S2001}
----------------

### Patient status {#S0003-S2001-S3001}

Among 554 randomized patients, 276 were treated with lumbar discectomy and additional ACD implantation, while 278 were treated with lumbar discectomy only. A total of 550 patients (272 ACD, 278 controls) with 3-year theoretical follow-up were included in this analysis; ACD implantation was not attempted in 4 patients because of the proximity of the nerve root to the intended device implantation location. There were 19 older patients (≥60 years) in each treatment group (6.9% of patients). Ultimately, 75% of patients returned for the 3-year follow-up visit.

### Preoperative data {#S0003-S2001-S3002}

When pooling preoperative data from both treatment groups, older patients had a lower frequency of smoking and herniated more frequently at lumbar levels versus at L5/S1 relative to younger patients. Older patients reported greater back-related disability than their younger counterparts and tended to present with more severe leg pain ([Table 1](#T0001){ref-type="table"}).Table 1Preoperative characteristics of older versus younger patients treated with lumbar discectomy^a^CharacteristicAge ≥60\
(n=38)Age \<60\
(n=512)Difference (95% CI)*P*-valueAge, years65.0±4.041.9±9.223.1 (21.6, 24.6)\<0.001Male sex24 (63.2)303 (59.2)4.0 (−12.4, 18.1)0.73Body mass index, kg/m^2^26.7±4.026.2±4.10.4 (−0.9, 1.8)0.55Current smoker9 (23.7)235 (45.9)−22.2 (−33.8, −6.1)0.01Lumbar (L1/L2 to L4/L5) herniation27 (71.1)214 (41.8)29.3 (12.9, 41.9)\<0.001Leg pain84.8±13.180.5±14.94.2 (−0.7, 9.1)0.09Oswestry Disability Index62.6±13.958.3±13.04.3 (0.0, 8.6)0.05Physical Component Summary score^b^27.4±7.028.9±6.0−1.5 (−3.5, 0.5)0.14Mental Component Summary score^b^40.4±13.640.6±12.9−0.2 (−4.5, 4.1)0.94[^1][^2]

### Predictors of reherniation and reoperation with lumbar discectomy {#S0003-S2001-S3003}

Among control patients treated with lumbar discectomy alone, higher ODI score, female sex, lower PCS score, and greater leg pain were associated with higher risk for symptomatic reherniation in univariate analysis, with only female sex (HR =1.72, *p*=0.02) and higher ODI (HR=1.22 per 10-point increase, *p*=0.01) remaining in the multivariate model. Univariate predictors of reoperation were female sex, lower PCS score, greater leg pain, and current smoking status, with only female sex (HR =2.81, *p*\<0.001) and current smoking (HR=1.31, *p*=0.004) remaining in the multivariate model. Age was not associated with the risk of symptomatic reherniation (*p*=0.68) or reoperation (*p*=0.66) ([Table 2](#T0002){ref-type="table"} and [Figure 1](#F0001){ref-type="fig"}).Table 2Predictors of symptomatic reherniation and reoperation risk over 3 years after lumbar discectomyCharacteristicUnit of measureSymptomatic reherniationReoperationHR95% CI*P*-valueHR95% CI*P*-valueUnivariate Cox model ODIPer 10-point increase1.261.07, 1.470.0041.090.90, 1.330.37 SexFemale vs male1.901.20, 2.990.0062.681.53, 4.70\<0.001 PCSPer 10-point decrease1.491.04, 2.110.031.551.00, 2.400.049 Leg painPer 10-point increase1.201.00, 1.410.051.261.01, 1.570.04 MCSPer 10-point decrease1.180.98, 1.410.081.160.94, 1.460.17 Current smokerYes vs no1.370.87, 2.160.182.171.24, 3.800.007 Age ^a^Per 10-year decrease1.050.84, 1.300.680.940.72, 1.220.66 Body mass indexPer 5-kg/m^2^ increase1.030.79, 1.360.830.940.67, 1.320.73 Level of herniationLumbar vs lumbosacral1.040.65, 1.660.861.010.57, 1.770.98Multivariate Cox model SexFemale vs male1.721.08, 2.740.022.811.60, 4.94\<0.001 ODIPer 10-point increase1.221.04, 1.410.01--------- Current smokerYes vs no---------2.301.31, 4.040.004[^3][^4] Figure 1Rates of symptomatic (Symp) reherniation and reoperation over 3 years after lumbar discectomy by age group.

### Effect of additional bone-anchored ACD implantation {#S0003-S2001-S3004}

Compared to lumbar discectomy alone, the clinical benefit of additional bone-anchored ACD implantation was comparable in older and younger patients. Over 3 years of follow-up, the risk of symptomatic reherniation was 12.5% with ACD versus 21.1% in controls in older patients and 14.8% versus 30.2% in younger patients. The corresponding HRs were 0.63 in older patients (indicating a 37% relative risk reduction with ACD) and 0.44 in younger patients (indicating a 56% relative risk reduction with ACD) ([Figure 2](#F0002){ref-type="fig"}). The benefit of bone-anchored ACD in preventing reoperation was also comparable between older and younger age groups. The risk of reoperation was 11.1% with ACD versus 26.3% in controls in older patients and 11.0% versus 18.8% in younger patients. The corresponding HRs were 0.41 in older patients (indicating a 59% relative risk reduction with ACD) and 0.55 in younger patients (indicating a 45% relative risk reduction with ACD) ([Figure 3](#F0003){ref-type="fig"}).Figure 2Risk of symptomatic reherniation over 3 years after lumbar discectomy with or without an annular closure device among older versus younger patients. The risk of symptomatic reherniation over 3 years was 30.2% (SE 3.1%) in younger controls, 21.1% (SE 9.4%) in older controls, 14.8% (SE 2.3%) in younger ACD patients, and 12.5% (SE 8.3%) in older ACD patients.**Abbreviation:** ACD, annular closure device.Figure 3Risk of reoperation over 3 years after lumbar discectomy with or without an annular closure device among older versus younger patients. The risk of reoperation over 3 years was 26.3% (SE 10.1%) in older controls, 18.8% (SE 2.5%) in younger controls, 11.1% (SE 7.4%) in older ACD patients, and 11.0% (SE 2.0%) in younger ACD patients.**Abbreviation:** ACD, annular closure device.

The percentage of patients who achieved the MCID while remaining free from a reoperation favored the ACD group for all patient-reported outcomes in older and younger patients. Among older patients comparing ACD to controls, success rates were 83.3% vs 70.6% for leg pain, 84.6% vs 70.6% for ODI, 83.3% vs 68.8% for PCS, and 53.8% vs 41.2% for MCS. Among younger patients, success rates were 80.4% vs 72.0% for leg pain, 81.9% vs 73.0% for ODI, 84.9% vs 75.1% for PCS, and 59.8% vs 46.5% for MCS ([Figure 4](#F0004){ref-type="fig"}). Comparing the ACD group to controls, the percentage of patients at 3 years who were free from reoperation and severe disability was 84.6% vs 58.8% in older patients and 81.4% vs 72.5% in younger patients.Figure 4Percentage of patients who achieved the MCID without a reoperation over 3 years after lumbar discectomy with or without an annular closure device for each patient-reported outcome among patients under 60 years old (left panel)^a^ and patients at least 60 years old (right panel)^b^. ^a^Among younger patients comparing ACD to controls, the rates were 80.4% vs 72.0% for leg pain, 81.9% vs 73.0% for ODI, 84.9% vs 75.1% for PCS, and 59.8% vs 46.5% for MCS. ^b^Among older patients comparing ACD to controls, the rates were 83.3% vs 70.6% for leg pain, 84.6% vs 70.6% for ODI, 83.3% vs 68.8% for PCS, and 53.8% vs 41.2% for MCS.**Abbreviations:** ACD, annular closure device; Con, control; MCID, minimal clinically important difference; MCS, Mental Component Summary; ODI, Oswestry Disability Index; PCS, Physical Component Summary.

Postmarket ACD registry outcomes {#S0003-S2002}
--------------------------------

A total of 268 patients from 2 postmarket registries were treated with lumbar discectomy and additional bone-anchored ACD implantation. Mean patient age was 46±14 years, with 46 (17.2%) older patients at least 60 years of age and 222 (82.8%) younger patients under 60 years of age. Mean preoperative leg pain severity was 78±21 and ODI was 51±20. Comparing older vs younger patients treated with the ACD, symptomatic reherniation rates were 3.2% vs 14.9% and reoperation rates were 0% vs 8.2%. The percentage of older vs younger patients who achieved the MCID without a reoperation at 2 years minimum follow-up was 80.0% vs 69.9% for leg pain and 92.7% vs 72.3% for ODI ([Table 3](#T0003){ref-type="table"}).Table 3Results of annular closure device postmarket registries by age groupCharacteristic≥60 years\<60 yearsSymptomatic reherniation through 3 years3.2% (SE 3.2%)14.9% (SE 6.6%)Reoperation through 3 years0%8.2% (SE 2.3%)Leg pain MCID responder^a^80.0% (32/40)69.9% (144/206)ODI MCID responder^a^92.7% (38/41)72.3% (149/206)[^5]

Discussion {#S0004}
==========

We examined for the first time the influence of patient age on surgical outcomes among patients with large annular defects following lumbar discectomy. With the benefit of approximately 1,500 patient-years of follow-up from a randomized trial and over 500 patient-years of follow-up from postmarket registries, we identified several important clinical findings. First, older patients with large postsurgical annular defects had a high risk of symptomatic reherniation and reoperation that was comparable to younger patients. Second, additional implantation of a bone-anchored ACD resulted in significant reductions in reherniation and reoperation risk, regardless of age. Finally, leg pain, disability, and quality of life greatly improved with lumbar disc surgery regardless of age, were durably maintained during follow-up, and favored patients treated with the ACD. Overall, these results highlight the clinical utility and patient-centric benefit of the additional use of a bone-anchored ACD in older, as well as younger, adults with large annular defects following lumbar disc surgery.

Sciatica secondary to lumbar disc herniation most often affects adults in their 40s and, therefore, the clinical impact of sciatica in older adults is likely underappreciated. Contrary to popular belief, sciatica is quite common among the elderly, affecting more than 20% of adults aged 65 and older.[@CIT0022] The negative impact of sciatica on quality of life in older adults is tremendous. The results of the current study suggest that older adults suffer from severe symptoms prior to discectomy surgery, and with a greater magnitude compared to their younger counterparts, a finding that has been confirmed by others.[@CIT0023] The preoperative disability associated with sciatica in the elderly is so incapacitating that affected individuals report a quality of life that is comparable to those with a history of COPD, stroke, or myocardial infarction.[@CIT0022] Thus, effective treatments for sciatica in the elderly should be identified since there is a paucity of clinical guidance specific to this underrepresented population.[@CIT0024],[@CIT0025]

We also observed that among patients with large postsurgical annular defects following lumbar discectomy, age was not associated with reherniation rates. This was a unique finding since it is commonly reported in the general discectomy literature that reherniation rates decline by 4% with every additional year of age,[@CIT0026] which is hypothesized to relate to the increasing disc degeneration that accompanies aging which protects against reherniation.[@CIT0027] It has also been suggested that older individuals undergoing surgery for lumbar disc herniation have inferior patient-reported outcomes compared to younger patients.[@CIT0023] However, in patients with large annular defects, it appears that reherniation risk remains at an increased level and is fairly stable during the lifespan. A possible explanation for this finding is that the influence of a large annular defect on the subsequent risk of reherniation may be much greater than the influence of patient age. Support for this hypothesis comes from the study of Kim et al.[@CIT0028] that reported a strong association of reherniation risk with large annular defects but no association with patient age. This implies that lumbar discectomy does not necessarily confer lower reherniation rates in older adults and that additional procedures may be warranted in high-risk patients with large defects in the annulus fibrosus.

Additional implantation of an ACD resulted in significant reductions in the risk of reherniation and reoperation, regardless of age. Comparing older to younger patients treated with an ACD, older patients derived similar or superior benefits across all study outcomes. Thus, age alone should not be a contraindication for lumbar surgery or for ACD implantation, provided the patient is fit for surgery. However, as a group, older patients suffering from sciatica tend to face more unique challenges that warrant additional consideration such as a higher risk of spinal osteoporosis, concomitant comorbidities that may influence surgical risk, and challenges in differential diagnosis owing to coexisting lumbar degenerative changes such as spinal stenosis.[@CIT0025],[@CIT0029] Independent of age, these surgical considerations should be weighed against the potential for symptom relief and associated quality-of-life benefits. Results of the current study, for the first time, demonstrate that lumbar discectomy with ACD implantation reliably and significantly reduces the risk of reherniation and reoperation and improves patient symptoms and quality of life, in older and younger patients alike.

Strengths of the randomized trial include results derived from 1,500 patient-years of follow-up and recruitment of the largest known sample of older adults with large postsurgical annular defects. The randomized, multicentric nature of the trial further improves generalizability of conclusions while minimizing bias. Additionally, we report here the largest known series of older adults treated with an ACD, the results of which were derived from a randomized trial and two real-world postmarket registries. There are also limitations of this study, which are mainly related to patient selection. First relates to annular defect size. It has been estimated that large annular defects are observed following approximately 30% of discectomy procedures.[@CIT0012] Patients with smaller defects may not benefit from ACD implantation since their reherniation risk is inherently lower. Thus, the results presented here are generalizable only to patients deemed to be a high risk for reherniation based on the size of the postsurgical defect. A second limitation relates to the sample size of the subgroups included in this analysis. While this study included the largest known sample of older patients with large annular defects, the sample size of 19 older ACD patients and 19 older controls has low power to detect clinically meaningful group differences and, therefore, age group comparisons were descriptive in nature. In order to overcome this limitation, we supplemented the results of the randomized trial with additional data derived from two large postmarket registries with the ACD. Results of these registries corroborated those from the randomized trial, which improves confidence in the overall conclusions of this study. Still, lack of a control group in the registries is an acknowledged limitation. Third, diseases that negatively impact bone quality (eg, lumbar osteoporosis or malignancy) or increase surgical complexity (eg, significant spondylolisthesis) preferentially impact the elderly. While such conditions are not absolute contraindications to lumbar disc surgery, they were exclusion criteria in the randomized trial reported here and, therefore, the performance of the ACD in the presence of these conditions is unclear. Finally, continued patient observation is warranted to determine whether the reported outcomes are maintained in long-term follow-up.

Conclusion {#S0005}
==========

Outcomes with lumbar discectomy and additional bone-anchored ACD are superior to lumbar discectomy alone. Older patients derived similar benefits with additional bone-anchored ACD implantation as younger patients.
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[^1]: **Notes:** ^a^Values are mean ± standard deviation, or count (percentage); ^b^Scores derived from the SF-36 questionnaire.

[^2]: **Abbreviations:** CI, confidence interval; SF-36, 36-Item Short Form Health Survey.

[^3]: **Notes:** ^a^Age was not associated with the risk of symptomatic reherniation or reoperation.

[^4]: **Abbreviations:** CI, confidence interval; HR, hazard ratio; MCS, Mental Component Summary; ODI, Oswestry Disability Index; PCS, Physical Component Summary.

[^5]: **Notes:** ^a^Percentage of patients who achieved the MCID without a reoperation through 2 years minimum follow-up.

    **Abbreviations:** MCID, minimal clinically important difference; ODI, Oswestry Disability Index; SE, standard error.
